FOLD · AMICUS THERAPEUTICS, INC.
$14.49
+0.00 (+0.00%)
At close · Apr 27
Market Cap
$4.55B
Shares
314.00M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$634.21M
+20%
FY2025
Net Income
-$27.11M
+51.7%
FY2025
Gross Margin
88.5%
-1.5pp
FY2025
Operating Margin
5.17%
+0.5pp
FY2025
Diluted EPS
-$0.09
+50%
FY2025
Operating Cash Flow
$33.15M
+197.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2028 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1B | — | $634.21M | $528.3M | $399.36M | $329.23M | $305.51M | $260.89M | $182.24M | $91.25M | $36.93M | $4.96M | — | $1.22M | $363K | $18.41M | $21.43M | $922K | $64.36M | — | — | — | — | — | — | |
| — | — | $72.93M | $52.94M | $37.33M | $38.6M | $34.47M | $31.04M | $21.96M | $14.4M | $6.24M | $833K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $561.28M | $475.35M | $362.03M | $290.63M | $271.05M | $229.84M | $160.27M | $76.84M | $30.69M | $4.13M | — | $1.22M | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | 88.5% | 89.98% | 90.65% | 88.28% | 88.72% | 88.1% | 87.95% | 84.21% | 83.11% | 83.2% | — | 100% | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $135.84M | $109.36M | $152.38M | $276.68M | $272.05M | $308.44M | $286.38M | $270.9M | $149.31M | $104.79M | $76.94M | $47.62M | $41.94M | $50.27M | $50.86M | $39.04M | $48.08M | — | — | — | — | — | — | |
| — | $67.57M | — | — | — | — | — | — | — | — | — | — | $47.27M | $20.72M | $18.89M | $19.36M | $19.88M | $15.66M | $19.97M | — | — | — | — | — | — | |
| — | — | $383.49M | $323.38M | $275.27M | $213.04M | $192.71M | $156.41M | $169.86M | $127.2M | $88.67M | $71.15M | $47.27M | $20.72M | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $3.3M | $3.3M | $2.5M | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $7.46M | $8.55M | $7.87M | $5.34M | $6.21M | $8.85M | $4.78M | $4.22M | $3.59M | — | $1.83M | $1.55M | $1.72M | $1.71M | $1.59M | $2.06M | $2.13M | — | — | — | — | — | — | |
| — | — | $0 | $9.19M | $0 | $0 | — | — | — | $0 | $0 | $69K | $15K | -$63K | $1.99M | $1.52M | $1.52M | — | $1.52M | — | — | — | — | — | — | |
| — | — | $528.49M | $450.48M | $439.24M | $502.75M | $477.48M | $476.84M | $464.31M | $405.62M | $472.68M | $186.02M | $130.44M | $69.93M | $64.54M | $71.34M | $72.32M | $56.76M | $71.71M | — | — | — | — | — | — | |
| — | — | $32.79M | $24.88M | -$77.21M | -$212.12M | -$206.43M | -$247M | -$304.04M | -$328.78M | -$441.99M | -$181.89M | -$130.44M | -$68.7M | -$64.18M | -$52.93M | -$50.89M | -$55.84M | -$7.35M | — | — | — | — | — | — | |
| — | — | 5.17% | 4.71% | -19.33% | -64.43% | -67.57% | -94.68% | -166.84% | -360.32% | -1196.82% | -3668.62% | — | -5612.83% | -17680.72% | -287.5% | -237.41% | -6056.18% | -11.42% | — | — | — | — | — | — | |
| — | — | $40.25M | $33.42M | -$69.34M | -$206.78M | -$200.23M | -$238.15M | -$299.26M | -$324.56M | -$438.39M | — | -$128.6M | -$67.15M | -$62.46M | -$51.23M | -$49.3M | -$53.78M | -$5.22M | — | — | — | — | — | — | |
| — | — | $46.16M | $49.6M | $50.15M | $37.12M | $32.47M | $22.43M | $18.87M | $22.4M | $17.24M | $5.4M | $1.58M | $1.48M | $46K | $89K | $148K | $260K | $278K | — | — | — | — | — | — | |
| — | — | $3.32M | $5.41M | $7.08M | $3.02M | $509K | $3.23M | $10.25M | $10.46M | $4.1M | $1.6M | $929K | $223K | $174K | $316K | $160K | $156K | $997K | — | — | — | — | — | — | |
| — | — | $10.24M | -$9.44M | -$15.89M | $4.18M | -$2.9M | -$781K | -$2.63M | -$5.63M | $6.01M | -$4.79M | -$80K | -$77K | $252K | $21K | $70K | $1.28M | $64K | — | — | — | — | — | — | |
| — | — | $191K | -$28.76M | -$150.1M | -$242.04M | -$241.55M | -$274.25M | -$355.91M | -$349.09M | -$449.12M | -$203.78M | -$132.12M | -$70.04M | -$63.15M | -$52.03M | -$48.04M | -$56.08M | -$6.57M | — | — | — | — | — | — | |
| — | — | $27.3M | $27.35M | $1.48M | -$5.47M | $8.91M | $2.6M | $478K | -$94K | -$165.12M | -$3.74M | — | -$1.11M | -$3.51M | -$3.25M | -$3.63M | -$1.14M | — | — | — | — | — | — | — | |
| — | — | -$27.11M | -$56.11M | -$151.58M | -$236.57M | -$250.46M | -$276.85M | -$356.39M | -$349M | -$284M | -$200.04M | -$132.12M | -$68.93M | -$59.63M | -$48.79M | -$44.41M | -$54.94M | -$6.57M | -$39.36M | -$41.17M | -$46.35M | -$19.97M | -$8.81M | -$6.77M | |
| — | — | -4.27% | -10.62% | -37.96% | -71.85% | -81.98% | -106.12% | -195.56% | -382.48% | -769.03% | -4034.73% | — | -5631.21% | -16427.82% | -264.98% | -207.2% | -5958.35% | -10.2% | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | -$200.04M | -$132.12M | -$68.93M | -$59.63M | -$48.79M | -$44.41M | -$54.94M | -$6.57M | — | — | — | — | — | — | |
| — | — | -$8.1M | -$56.25M | -$134.24M | -$253.65M | -$253.71M | -$271.45M | -$353.63M | -$346.45M | -$288.14M | -$197.88M | -$132.1M | -$69.06M | -$59.65M | -$48.78M | -$44.38M | -$55.01M | -$7.06M | -$39.23M | -$40.77M | -$46.31M | -$19.98M | -$8.82M | — | |
| USD/shares | — | — | -$0.09 | -$0.18 | -$0.51 | -$0.82 | -$0.92 | -$1.07 | -$1.48 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | — | -$0.09 | -$0.18 | -$0.51 | -$0.82 | -$0.92 | -$1.07 | -$1.48 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | 308.36M | 304.38M | 295.16M | 289.06M | 271.42M | 258.87M | 240.42M | 185.79M | 153.36M | 134.4M | 109.92M | 74.44M | 51.29M | 45.57M | 34.57M | 27.73M | — | — | — | — | — | — | — |
| shares | — | — | 308.36M | 304.38M | 295.16M | 289.06M | 271.42M | 258.87M | 240.42M | 185.79M | 153.36M | 134.4M | 109.92M | 74.44M | 51.29M | 45.57M | 34.57M | 27.73M | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.41×
EV/EBIT
—
Biotechnology median 26.60×
P/E (TTM)
—
Biotechnology median 7.07×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Non Us | $370,184,000 | $322,148,000 | $252,419,000 | $213,287,000 | $210,127,000 | $180,840,000 | $129,759,000 | $84,022,000 |
| United States | $264,026,000 | $206,147,000 | $146,937,000 | $115,946,000 | $95,387,000 | $80,046,000 | $52,478,000 | $7,223,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Galafold | $521,702,000 | $458,054,000 | $387,777,000 | $329,046,000 |
| Pombiliti Opfolda | $112,508,000 | $70,241,000 | $11,579,000 | $187,000 |